What's breaking now, across thousands of outlets.
The muscular dystrophy drug that Servier bought for $1.55 billion upfront has already failed its pivotal trial. The drug, called sevasemten, failed the primary and secondary endpoints in the GRAND CANYON pivotal ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Don’t sit on the sidelines during open enrollment.
Don’t sit on the sidelines during open enrollment.
The health insurance system is about to send 29-year-old men and women a message on fertility issues, a key measure in the government’s anti-infertility plan launched in February.
Fish that are cultivated in pools or ponds are an increasingly important source of food around the world. Unfortunately, disease outbreaks can cause substantial losses in aquaculture.
In a recent study, more than half of young adults entered remission for type 2 diabetes with lifestyle changes. Luis Alvarez · DigitalVision/Getty A new trial found that 54% of adults with early onset…
(MedPage Today) -- A large nationwide study found an association between cooler ambient temperature and heart failure (HF) hospitalizations.
